Dialog Box

Latest news
See all news
17 Jun 2019 at 12:00AM

Study shows immunotherapy combination shrinks rare NET cancer

Recent research from the US shows scientists have found that rare and aggressive neuroendocrine tumours shrink through a combination of two common immunotherapy drugs.

Research results were presented at the American Association for Cancer Research Annual Meeting 2019 and show a significant clinical benefit for patients with high-grade neuroendocrine carcinoma.

Read full article here

Category: Research